Hosted By
Is it important for MDs to consider taking a more prominent role in the process of developing and getting drugs to market, either on the operating side or the investing side? How can we change and fix financial incentives in drug development? In this episode, we answer all these questions and more with our guest, David Kaufman, M.D.
David is a Partner at Third Rock Ventures, a leading healthcare venture firm that specializes in company creation rather than the traditional venture investing model.
David has an MD from Cornell University, and a PHD in immunology and molecular virology from Rockefeller University.
How important is it to have a teamwork mentality in medicine? What values does humanitarian work add to someone’s perspective, and how can it...
What is the mission of big corporations in the healthcare business? How is AI going to impact the drug development continuum in the next...
What factors must we overcome for healthcare Machine Learning to reach its full potential? How can LMICs globally be included in the healthcare informatics...
